Talisman Therapeutics Limited
08473331
Healthy
No risk factors detected.
Details
Compliance
Last accounts
30/04/2025
total exemption full
Next accounts due
31/01/2027
Confirmation statement
Last: 18/03/2026
Due 01/04/2027
Industry
Officers
Former
director · Resigned 20/09/2016
Persons with Significant Control
Dr Frederick John Livesey
Irish · England · Age 57
Babraham Hall, Babraham Research Campus, Cambridge, CB22 3AT
Notified 06/04/2016
Change History
Active
Private Limited Company
BABRAHAM HALL
CAMBRIDGE
CompanyRankvs 67+ SIC 72110 peers85
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/04/2026
Net Worth
£755k
Balance sheet strength
Cash
£336k
Cash in the bank
Net Current Assets
£638k
Working capital
Current Assets
£850k
Current Liabilities
£212k
Fixed Assets
£117k
Debtors
£514k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2026 | 4.01 | +£114k |
| 2025 | 3.11 | — |
Derived from filed accounts. Not audited figures.